Triethylamine → (4-Chloropyridin-2-yl)-(5-fluoro-2,3-dihydroindol-1-yl)-methanone
반응식
[F:1][C:2]1[CH:3]=[C:4]2[C:8](=[CH:9][CH:10]=1)[NH:7][CH2:6][CH2:5]2.[Cl:11][C:12]1[CH:17]=[CH:16][N:15]=[C:14]([C:18](O)=[O:19])[CH:13]=1.C(N(CC)CC)C.CN(C(ON1N=NC2C=CC=CC1=2)=[N+](C)C)C.[B-](F)(F)(F)F>CN(C=O)C>[Cl:11][C:12]1[CH:17]=[CH:16][N:15]=[C:14]([C:18]([N:7]2[C:8]3[C:4](=[CH:3][C:2]([F:1])=[CH:10][CH:9]=3)[CH2:5][CH2:6]2)=[O:19])[CH:13]=1참가 물질
6
반응물 4
생성물 1
시약·촉매·용매 1
실험 절차
174 mg (1.27 mmol) 5-fluoro-2,3-dihydro-1H-indole were added to 200.0 mg (1.27 mmol) 4-chloropyridine-2-carboxylic acid, 351 μL (2.50 mmol) triethylamine and 434.0 mg (1.35 mmol) TBTU in 3 mL DMF. The reaction mixture was stirred overnight at RT. Purification was carried out by preparative HPLC. The product fractions were combined and evaporated down i. vac.
후처리
- customPurification
- customevaporated down i
출처 및 근거
- ORD 기록
- ord-2734c073f2eb46e681607cbaafcd9340
- 출처 데이터셋
- uspto-grants-2014_09
- 특허 번호
- US08829006B2
반응 노트
불러오는 중…